about
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials.Central venous catheters and cardiac tamponade in preterm infants.β3-adrenoreceptor and tumor microenvironment: a new hub.New developments in the treatment of hyperammonemia: emerging use of carglumic acid.The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Fetal programming and systemic sclerosis.Expression of β-adrenergic receptors in pediatric malignant brain tumors.Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials.Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study.N-carbamylglutamate in emergency management of hyperammonemia in neonatal acute onset propionic and methylmalonic aciduria.Umbilical cord care in premature infants: the effect of two different cord-care regimens (salicylic sugar powder vs chlorhexidine) on cord separation time and other outcomes.Propranolol concentrations after oral administration in term and preterm neonates.Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.Brain hemodynamic effects of doxapram in preterm infants.Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.Dopamine infusion and anterior pituitary gland function in very low birth weight infants.Temporary epicardial pacing in an extremely low-birth-weight infant with congenital atrioventricular block.Congenital syphilis: unique clinical presentation in three preterm newborns.Effects of pressure support ventilation plus volume guarantee vs. high-frequency oscillatory ventilation on lung inflammation in preterm infants.The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy.Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo.Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization.Paradoxical embolism in a preterm infant.Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.Does pulmonary function change during whole-body deep hypothermia?Early postnatal doppler assessment of cerebral blood flow velocity in healthy preterm and term infants.Hypothermia for neonatal hypoxic-ischemic encephalopathy: may an early amplitude-integrated EEG improve the selection of candidates for cooling?Haematohidrosis treated with propranolol: a case report.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study.Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial.Congenital microgastria and primary ciliary dyskinesia in a newborn with DiGeorge syndrome and 22q11.2 deletion.Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.Protective effects of β1/2 adrenergic receptor deletion in a model of oxygen-induced retinopathy.
P50
Q30992212-3F8E7419-63B0-4A11-8165-E76F15329E31Q33431654-6C454776-4EE9-48B5-91EE-C4EAEA31D5BDQ34569672-C3A503FE-9068-4305-898D-A19A9D6DF339Q35934285-703CA6B6-3598-4E21-B218-132C57283438Q36107924-04A4F9AA-AE15-4E3F-8E3F-F5DE427E027CQ37853025-A85034C5-EC2B-4291-9908-C55CE45D05BDQ38101684-8304FA34-F148-4781-83C1-9F7FAA042D36Q38220562-172BEBBF-0B41-4579-B6EB-18A805C70BC4Q38293740-0507206D-973F-4E5A-9D1D-9FC54690BB0EQ38373964-F2BE137B-D344-49E5-BAC3-2BFC12E37EA2Q40671281-B08BAF8B-EBE9-4C38-8495-03BE2BB86098Q41902409-0525C54A-8872-45F9-A31A-35E45B593DDDQ42376142-66269339-CAD2-402B-B65E-5CA69F643459Q43018024-B32263D7-3AD3-40BC-BA7A-245136D5956AQ43249006-F941485F-1975-441B-803F-7DA3D741F69CQ44605395-919225A8-8AAC-49CB-B5CE-A1E281BE0A75Q44663019-B4F54F57-5560-483F-A999-8DA2C5E52B67Q45418272-4C46297F-52C5-465D-8071-EA5C4D63491EQ46672998-0CC0D2D4-7448-4D9B-82FC-A8565C70CD2AQ46699401-3BB25BA9-2D3F-406C-AF6F-9C707BCD96C7Q46968429-401162B2-EFE5-4FA9-BCE1-27EE17F9A071Q46969201-BA8698CA-BDC1-4805-A395-6BCF86B61570Q47239689-4D55B1B2-BBD2-48C8-9241-04FE88BFD044Q47599747-B992D95B-8624-493C-97FE-60D4665C8613Q47659002-4985B6A6-3C7A-495C-B61F-1736164CA849Q47708800-E56E0ECF-1227-4F66-8FD6-93BD25D49031Q47861667-F247DA6F-EB3D-4798-9A10-8B2872DDD6A3Q47880195-72877F50-9018-4A56-91A0-CB65EE3AD1BDQ47914995-9D362611-70AB-4AD6-8C19-3EBEDB049D34Q47968906-911066B6-5972-4206-84E9-7BB04D04E4E2Q48174026-7BE5A50B-3DD4-415A-AF56-69CA0FAB1150Q48452923-68F7393B-A777-4524-AFCC-85D355951144Q48566230-F4F7B7BA-7EB0-4ADA-8A57-998F79EFC34BQ50056350-26FDF1EE-BBC2-45EC-BEF2-95B526716FDCQ50310697-EE35D19B-ADA7-4379-8CBE-DBA6BA7C02B9Q50442563-03C7A212-290E-4A8D-B7B1-D72FC2F75B3EQ51425178-AD7C2847-3BF7-4C04-973E-BA0F3FEC2426Q51701606-AFF08C33-0C62-485E-B5AC-696C5DF104DFQ53574698-D75E4A09-3D6F-4E5C-B560-782944CA839BQ53662806-E5C5B15C-21B7-419B-BB88-0560B361022E
P50
description
researcher ORCID: 0000-0001-5310-9147
@en
wetenschapper
@nl
name
Luca Filippi
@ast
Luca Filippi
@en
Luca Filippi
@es
Luca Filippi
@nl
Luca Filippi
@sl
type
label
Luca Filippi
@ast
Luca Filippi
@en
Luca Filippi
@es
Luca Filippi
@nl
Luca Filippi
@sl
prefLabel
Luca Filippi
@ast
Luca Filippi
@en
Luca Filippi
@es
Luca Filippi
@nl
Luca Filippi
@sl
P106
P1153
7003651572
P21
P31
P496
0000-0001-5310-9147